The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug Blenrep, when used in combination with other treatments, may cause eye damage in ...

A combination of routine eye scans and AI has created a powerful new way of measuring nearsightedness to better predict ...